Carmen Saez
Sevilla, AN 41013, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels.
Journal: Cancers
Published: June 03, 2025
βTrCP facilitates MRN complex localization on chromatin to enhance DNA repair.
Journal: Communications biology
Published: November 26, 2024
β-TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1.
Journal: Molecular oncology
Published: November 12, 2024
Overexpression of βTrCP1 elicits cell death in cisplatin-induced senescent cells.
Journal: Cell death & disease
Published: October 14, 2024
Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review).
Journal: International journal of molecular sciences
Published: July 20, 2023
Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway.
Journal: Cell death and differentiation
Published: May 27, 2022
PARP Inhibitors: A New Horizon for Patients with Prostate Cancer.
Journal: Biomedicines
Published: April 27, 2022
Wnt/β-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties.
Journal: International journal of molecular sciences
Published: November 16, 2021
EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells.
Journal: Cell death discovery
Published: February 24, 2020
p53 and FBXW7: Sometimes Two Guardians Are Worse than One.
Journal: Cancers
Published: February 10, 2020
Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.
Journal: Cancers
Published: January 09, 2019
Last Updated: 09/26/2026